单独ECMO与心脏性休克患者的ECPELLA:多中心EVACS研究
Antonio Piperata1, Jef Van den Eynde2,3, Charles-Henri David4
1From the CHU Bordeaux, Department of Cardiovascular Anesthesia and Critical Care, Bordeaux, France.
静脉外体膜氧化 (ECMO) 与Impella卸载 (ECPELLA) 和单独ECMO显示,心脏性休克患者的30天和1年的生存率相似. 这两种策略都对机械循环支持有效.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 关键护理医学 关键护理医学
背景情况:
- 心脏性休克是一种危及生命的疾病,需要机械循环支持.
- 静脉外体膜氧化 (ECMO) 是一种关键疗法,但左心室卸载可以改善结果.
- 在ECPELLA中,ECMO与Impella左心室卸载相结合.
研究的目的:
- 为了比较ECPELLA与单独ECMO在心脏性休克患者的临床结果.
- 评估30天死亡率,并发症率和长期存活率.
- 评估ECMO和左心室卸载联合的有效性.
主要方法:
- 来自4个国际中心的438名需要机械循环支持的患者的回顾性分析.
- 仅ECMO (319名患者) 和ECPELLA (119名患者) 的比较.
- 倾向性得分匹配创建了95对对来进行可靠的结果比较.
主要成果:
- 单独使用ECPELLA (43.2%) 和单独使用ECMO (49.5%) (P=0.467) 之间30天死亡率没有显著差异.
- 在两组之间观察到类似的并发症发生率 (P>0.05对所有人).
- 一年整体存活率是可比的:ECPELLA的51.3%,仅ECMO的46.6% (HR0.81,P=0.285).
结论:
- 单独使用ECMO和ECPELLA都是有效的策略来管理心脏性休克.
- 在ECMO中添加Impella的左心室卸载并不会显著改变早期或中期存活率.
- 进一步的研究可能会探索特定的患者亚组,这些患者可能会从ECPELLA中获益更多.
更多相关视频
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
相关概念视频
Heart Failure Drugs: Inotropic Agents
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-IV
